Findings seen for Black patients presenting to the emergency department
MONDAY, July 7, 2025 (HealthDay News) — Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), according to a study published online July 2 in JAMA Network Open.
Siri Shastry, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined racial and ethnic disparities in treatment referral rates in emergency department patients with opioid overdose. The analysis included data from 10 hospital sites (1,683 patients) participating in the Toxicology Investigators Consortium Fentalog Study (Sept. 21, 2020, to Nov. 11, 2023).
The researchers found that 17.8 percent of patients presenting to the emergency department received a referral for outpatient treatment, 42.4 percent received a naloxone kit or prescription, and 8.4 percent received a buprenorphine prescription. Black patients had a decreased likelihood of outpatient treatment referral (adjusted odds ratio, 0.67) compared with White patients. Hospital admission was associated with an increased likelihood of outpatient treatment referral (adjusted odds ratio, 3.13). There was geographic variation noted for all primary and secondary outcomes.
“In this study, Black patients were less likely to receive outpatient referrals for OUD,” the authors write. “These findings underscore the need for targeted interventions to address racial disparities in emergency department care for OUD, particularly in enhancing referral processes.”
Withdrawal From Medetomidine Increasingly Seen in ICUs
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Multicomponent Interventions Offer Little Impact on Fall Risk
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer